136 related articles for article (PubMed ID: 3409177)
1. Significance of systemic mast cell disease with associated hematologic disorders.
Travis WD; Li CY; Yam LT; Bergstralh EJ; Swee RG
Cancer; 1988 Sep; 62(5):965-72. PubMed ID: 3409177
[TBL] [Abstract][Full Text] [Related]
2. Hematologic manifestations of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis.
Lawrence JB; Friedman BS; Travis WD; Chinchilli VM; Metcalfe DD; Gralnick HR
Am J Med; 1991 Dec; 91(6):612-24. PubMed ID: 1750431
[TBL] [Abstract][Full Text] [Related]
3. Hematologic aspects of systemic mastocytosis.
Parker RI
Hematol Oncol Clin North Am; 2000 Jun; 14(3):557-68. PubMed ID: 10909040
[TBL] [Abstract][Full Text] [Related]
4. [Systemic mastocytosis and secondary acute myeloid leukemia].
Galán Alvarez P; Ibáñez García J; Funes Vera C; López García-Carreño MD; Alix Trueba A; Pérez Guillermo M; Alberola C
An Med Interna; 1999 Sep; 16(9):466-8. PubMed ID: 10609361
[TBL] [Abstract][Full Text] [Related]
5. Hematologic aspects of mastocytosis: II: management of hematologic disorders in association with systemic mast cell disease.
Parker RI
J Invest Dermatol; 1991 Mar; 96(3):52S-53S; discussion 53S-54S. PubMed ID: 2002265
[TBL] [Abstract][Full Text] [Related]
6. Splenectomy in the management of systemic mast cell disease.
Friedman B; Darling G; Norton J; Hamby L; Metcalfe D
Surgery; 1990 Jan; 107(1):94-100. PubMed ID: 2404352
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow mast cell morphologic features and hematopoietic dyspoiesis in systemic mast cell disease.
Stevens EC; Rosenthal NS
Am J Clin Pathol; 2001 Aug; 116(2):177-82. PubMed ID: 11488063
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow angiogenesis in systemic mast cell disease.
Baek JY; Li CY; Pardanani A; Butterfield JH; Tefferi A
J Hematother Stem Cell Res; 2002 Feb; 11(1):139-46. PubMed ID: 11847010
[TBL] [Abstract][Full Text] [Related]
9. Systemic mast cell disease without associated hematologic disorder: a combined retrospective and prospective study.
Pardanani A; Baek JY; Li CY; Butterfield JH; Tefferi A
Mayo Clin Proc; 2002 Nov; 77(11):1169-75. PubMed ID: 12440552
[TBL] [Abstract][Full Text] [Related]
10. Solid and hematologic malignancies in 60 patients with systemic mast cell disease.
Travis WD; Li CY; Bergstralh EJ
Arch Pathol Lab Med; 1989 Apr; 113(4):365-8. PubMed ID: 2650653
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of mast cells in myeloproliferative disorders and myelodysplastic syndromes.
Dunphy CH
Arch Pathol Lab Med; 2005 Feb; 129(2):219-22. PubMed ID: 15679425
[TBL] [Abstract][Full Text] [Related]
12. Systemic mast cell disease: a clinical and hematopathologic study of 26 cases.
Webb TA; Li CY; Yam LT
Cancer; 1982 Mar; 49(5):927-38. PubMed ID: 6174198
[TBL] [Abstract][Full Text] [Related]
13. Hematologic aspects of mastocytosis: I: Bone marrow pathology in adult and pediatric systemic mast cell disease.
Parker RI
J Invest Dermatol; 1991 Mar; 96(3):47S-51S. PubMed ID: 2002263
[TBL] [Abstract][Full Text] [Related]
14. Systemic mast cell disease associated with the hypereosinophilic syndrome.
McElroy EA; Phyliky RL; Li CY
Mayo Clin Proc; 1998 Jan; 73(1):47-50. PubMed ID: 9443678
[TBL] [Abstract][Full Text] [Related]
15. Systemic mast cell disease (mastocytosis). General aspects and histopathological diagnosis.
Horny HP; Ruck P; Kröber S; Kaiserling E
Histol Histopathol; 1997 Oct; 12(4):1081-9. PubMed ID: 9302569
[TBL] [Abstract][Full Text] [Related]
16. Hematologic aspects of mastocytosis: II: Management of hematologic disorders in association with systemic mast cell disease.
Parker RI
J Invest Dermatol; 1991 Mar; 96(3 Suppl):52S-53S; discussion 53S-54S, 60S-65S. PubMed ID: 16799610
[TBL] [Abstract][Full Text] [Related]
17. Hematologic aspects of mastocytosis: I: Bone marrow pathology in adult and pediatric systemic mast cell disease.
Parker RI
J Invest Dermatol; 1991 Mar; 96(3 Suppl):47S-51S; discussion 50S, 60S-65S. PubMed ID: 16799609
[TBL] [Abstract][Full Text] [Related]
18. Systemic mast cell disease. Analysis of 58 cases and literature review.
Travis WD; Li CY; Bergstralh EJ; Yam LT; Swee RG
Medicine (Baltimore); 1988 Nov; 67(6):345-68. PubMed ID: 3054417
[TBL] [Abstract][Full Text] [Related]
19. Systemic mast cell disease associated with hairy cell leukaemia.
Petrella T; Depret O; Arnould L; Maynadie M; Guy H; Dalac S; Caillot D; Casasnovas O; Lombard JN
Leuk Lymphoma; 1997 May; 25(5-6):593-5. PubMed ID: 9250832
[TBL] [Abstract][Full Text] [Related]
20. Blood findings in generalized mastocytosis: evidence of frequent simultaneous occurrence of myeloproliferative disorders.
Horny HP; Ruck M; Wehrmann M; Kaiserling E
Br J Haematol; 1990 Oct; 76(2):186-93. PubMed ID: 2128807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]